In elderly patients with head and neck cancer, a safe and radical treatment with which the incidence of systemic side effects is low is required. We developed a new combination intra-arterial and intra-venous chemotherapy with docetaxel (TXT), cisplatin (CDDP), peplomycin (PEP), and 5-FU (TCPF intra-arterial chemotherapy), and evaluated its usefulness and safety in such patients.
From March 2002 to May 2005, 10 patients aged over 75 years with oral squamous cell carcinoma were treated with TCPF intra-arterial chemotherapy. The patients consisted of 5 males and 5 females aged from 75 to 84 years (median age, 80 years). The tumors were located in the tongue or oral floor in 8 patients, the buccal mucosa in one, and the upper gingiva in one. A catheter for intra-arterial administration was inserted via the superficial temporal artery or occipital artery. Continuous intra-arterial administration of 15 mg/m
2 TXT (day 1-5) and 10 mg/body PEP (day 6-10), intra-arterial administration of 7-15 mg/m
2 TXT (day 3) and 7-15 mg/m
2 CDDP (day 4, 5), and continuous intravenous administration of 250 mg/body/day 5FU (day 1-10) were performed as 1 course. The second course was performed 4 weeks after the completion of the first course in patients for whom it was required. Radiotherapy was additionally performed in one patient. Excision biopsy in 7 patients, and radical excision in 2 were performed after the completion of this treatment.
The effects of this method on the primary lesions were CR 8/10 (80%), PR 2/10 (20%), and pathological CR 6/9 (67%). As side effects, no cerebrovascular disorder was detected, but grades 2-3 mucositis and alopecia on the intra-arterial administration side were observed, without marked systemic disorders. These results indicated that this chemotherapy is useful and safe, and can be applied to as a radical treatment method elderly patients with high risks.
View full abstract